Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |